Cross-sectional study assesses adverse effects of antidepressants in patients, highlighting safety improvements needed.
Given the high frequency of predictable Type A ADRs and the increased metabolic effects observed with combination therapy, these findings emphasize the need for routine monitoring and strengthened PV practices to improve antidepressant safety in resource-limited settings like Nepal.
No takes yet. Share an insight, caveat, or question.
Acharya et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: